SNCA and Parkinson disease: Finally, to assess whether human anti-α-synuclein antibodies aSyn-323.1, aSyn-336.1 and aSyn-338.1 recognize actual Lewy pathology, we conducted immunohistochemistry on post-mortem PD brain tissue.